Aditec in the media

Aditec regularly shows up in a diverse range of media productions. Here is a short overview (not complete):

 

• Boon or burden: what has the EU ever done for science? Nature 16 June 2016
• Tuberculosi. Strade nuove per il vaccino. L'Espresso, 20 February 2014
• Sigmoid Pharma Completes Phase II trial of CyCol™ in more than 100 Ulcerative Colitis Patients and Raises €3 million, Business Wire, 17 May 2012, also on Bloomberg
• Joining forces for better vaccines, EMBO encounters, summer 2012
• Intercell AG : announces Q3 2011 results and provides an update on ongoing operations, 4-traders.com, 8 November 2011

Results 1st ADITEC press release

Italy

Nove da Firenze: Parte il progetto ADITEC - Advanced Immunization Technologies

Siena news: Sclavo Vaccines Association e Università di Siena insieme nel progetto ADITEC

Il Cittadino: Sclavo Vaccines Association coordina il progetto Aditec

Sanità in cifre: Vaccini, l’Iss partecipa al progetto europeo ADITEC per aumentarne sicurezza ed efficacia

GuidaFormazione: Parte il progetto ADITEC- Advanced Immunization Technologies  

FAI Informazione: Vaccini, l’Iss partecipa al progetto europeo ADITEC per aumentarne sicurezza ed efficacia

Weblog Antonio Caperna: Vaccini, progetto ADITEC: IRB di Bellinzona tra i partner di ricerca

Controcampus: Università di Siena: parte il progetto ADITEC

Antenna Radio Esse: Ricerca scientifica: Siena conferma il suo ruolo di protagonista

Libero: Parte il progetto ADITEC - Advanced Immunization Technologies

Siena Free: Al via il progetto ADITEC: Siena capitale mondiale dei vaccini

Il Taggatore: IRB, EU invests €30 million to boost vaccine research

France

Le quotidien du medecin: 30 millions pour la recherche vaccinale en Europe

Spain

Emprendia: Nuevo proyecto europeo de investigación de nuevas vacunas

Myether.net: Proyecto ADITEC

The Netherlands

Krant van Flevoland: Vaccinonderzoek: EU investeert € 30 miljoen

Nieuwsbank: EU boosts vaccine research with €30 mln

Utrecht Science Park: EU investeert €30 miljoen in vaccinonderzoek

Utrechtnieuws.nl: Universiteit Utrecht zoekt mee naar nieuwe generatie vaccins

Nationale zorggids: Universiteit Utrecht zoekt mee naar nieuwe generatie vaccins

Agrarisch Dagblad: EU investeert 30 miljoen in vaccin-onderzoek

Dier en arts: EU investeert 30 miljoen in vaccin-onderzoek

Medical Facts: Universiteit Utrecht zoekt mee naar nieuwe generatie vaccins

Pharmasite.nl: EU investeert 30 miljoen euro in vaccinonderzoek

Dutch Vaccines Group: EU investeert 30 miljoen euro in vaccinonderzoek

Flevopost: EU investeert 30 miljoen euro in vaccinonderzoek

Austria

FriedlNews: Intercell: EU Invests € 30m in Research Program

Aktien forum: EU investiert EUR 30 Mio. in die Impfstoffforschung

Analyst Award: EU investiert 30 Mio. Euro in Impfstoff-Forschung

Oesterreich Journal: EU investiert EUR 30 Mio. in die Impfstoffforschung

Die Presse: Impfstoffe haben die Medizin revolutioniert. Dennoch gibt es noch viele Lücken im immunologischen Wissen. Die EU startet daher nun ein riesiges Forschungsprojekt.

Kronen Zeitung Tirol: Großes EU-Projekt: Innsbruck forscht mit

Switzerland

Swissbiotech.org: Pevion participates in €30 million EU vaccine research project

Techno-science (linking to approx. 15 other websites): Vers des vaccins plus efficaces et tout aussi sûrs

Tribune de Geneve: Nouveaux vaccins: un million d’euros pour des chercheurs genevois

Association des Médecins du canton de Genève: Vers des vaccins taillés sur mesure

MyScience: Vers des vaccins plus efficaces et tout aussi sûrs - Plus d’un million d’euros pour un projet genevois en vaccinologie

Centre de Documentation en Santé Publique & InfoDoc Promotion de la Santé: Vers des vaccins taillés sur mesure : l'Europe lance un vaste programme de recherche

24 Heures: Nouveaux vaccins: un million d’euros pour des chercheurs genevois

Le Matin : Nouveaux vaccins: un million d’euros pour des chercheurs genevois

Le Temps : Vers des vaccins personnalisés (via login)

Schotland

Compute Schotland: Immunisation in Europe, Spain and Canada

Enterprise Europe Network: EUR 30 million in EU funding for new vaccines

Germany

Boerse express.com: EU investiert 30 Mio. Euro in Impfstoff-Forschung

Bionity.com: EU invests €30 million to boost vaccine research

Life Sciences Germany The EU Boosts Vaccine Research with €30 Million". Brussels.

Sweden

Lifescience Stockholm Uppsala Xbrane Bioscience receives 4 million SEK

Biotech Sweden EU satsar 265 miljoner på vaccinforskning

USA

WUSA9.com: EC provides EUR 30M to international vaccine program

Georgia research alliance: Emory Vaccine Center joins partnership to advance vaccine R&D worldwide

The Emory Wheel: Univ. Joins Worldwide Vaccine Research

DigitalJournal: IDRI Partners With Global Research Initiative ADITEC to Accelerate Human Vaccine Development

News Online: IDRI joins ADITEC to accelerate human vaccine development

Manufacturing chemist: IDRI joins ADITEC vaccine development project

Greece:

BTM news: EUR 30 million in EU funding for new vaccines

Denmark:

Berlingske: Ny influenzavaccine kan virke i årevis

International

InfoGrokPharma: Intercell to Begin EC Funded ADITEC Program

Biocentury: EC provides EUR 30M to international vaccine program

Stop TB Partnership: European Union invests 30 million Euros in new vaccine research programme

Bioportfolio: EU invests €30 million to boost vaccine research

TB Online: EU invests €30 million to boost vaccine research

Euroalert.net: €30 million in EU funding to speed up the development of new vaccines

4-traders: Intercell AG : EU invests €30 million to boost vaccine research

Websites ADITEC partners

Cordis Europe: EUR 30 million in EU funding for new vaccines

European Commission, research and innovation: The EU boosts vaccine research with €30 Million

IBA: Collaborative EU-project ADITEC

IRB: EU invests €30 million to boost vaccine research, the IRB is one of the 42 grantees

USI: La Commissione europea investe 30 milioni di euro per promuovere la ricerca sui vaccini: l'IRB è parte del programma (29.09.2011)

University of Utrecht: EU invests €30 million to boost vaccine research 

EU investeert €30 miljoen in vaccinonderzoek

Xbrane: EU invests €30 million to boost vaccine research

Pevion: Pevion participates in €30 million EU vaccine research project

TBVI: EU invests €30 million to boost vaccine research

SSI: Forskere på Statens Serum Institut er centrale partnere i EU's 250 millioner kroner store investering i vaccineforskning

University of Geneva: Vers des vaccins plus efficaces et tout aussi sûrs - Plus d'un million d'euros pour un projet genevois en vaccinology

Hopiteuax Universitaires de Geneve: Vers des vaccins plus efficaces et tout aussi sûrs

Intercell : EU invests €30 million to boost vaccine research

University of Gothenburg:  http://www.gu.se/omuniversitetet/aktuellt/nyheter/nyheterdetalj//44-miljoner-kronor-till-goteborgs-universitet-fran-fas.cid10416094 miljoner kronor till Göteborgs universitet från FAS

Göteborgsforskare ska utveckla nästa generation vacciner

Austrian Academy of Sciences: EU investiert EUR 30 Mio. in die Impfstoffforschung

ISS: Vaccini, l’ISS partecipa al progetto europeo ADITEC per aumentarne sicurezza ed efficacia

Vaccibody: EU invests €30 million to boost vaccine research

BMI Oslo: Vaccibody partner in ADITEC

Xbrane: EU invests €30 million to boost vaccine research

Institut Pasteur: L’Union Européenne investit 30 millions d’euros pour renforcer la recherche vaccinale

Emory: Emory Vaccine Center Partners with Global Initiative to Boost Vaccine Research and Development